CARROLL PHILLIPS: Open Payments
NPI 1003244047 · MC MURRAY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,304 in 65 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $109 · 2025 $1,304
Food & beverage: $1,304
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $231 |
| Vanda Pharmaceuticals Inc. | 10 | $167 |
| Axsome Therapeutics, Inc. | 4 | $153 |
| Neurocrine BioSciences, Inc. | 10 | $138 |
| Alkermes, Inc. | 6 | $106 |
| Teva Pharmaceuticals USA, Inc. | 5 | $97 |
| Janssen Pharmaceuticals, Inc | 5 | $97 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $70 |
| Lundbeck LLC | 4 | $70 |
Products named: VRAYLAR, Auvelity, INGREZZA, ARISTADA, REXULTI, HETLIOZ, FANAPT, CAPLYTA.
Industry payments across PA — which companies pay providers there.
